康弘药业：关于公司收到药物临床试验批准通知书的公告

Core Viewpoint - Kanghong Pharmaceutical has received the clinical trial approval notice from the National Medical Products Administration for its drug KHN707 tablets [2] Group 1 - The drug KHN707 is set to undergo clinical trials following the approval [2] - The announcement was made on February 25 [2]